Cargando...
Novel Experimental Drugs for Treatment of Multiple Myeloma
Multiple myeloma (MM) is the second most frequent hematological malignancy characterized by bone marrow aberrant plasma cells proliferation leading to a genetic complex and heterogeneous disease, with a median survival ranging from two to more than 10 years. By using new drugs such as proteasome inh...
Guardado en:
| Publicado en: | J Exp Pharmacol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7955760/ https://ncbi.nlm.nih.gov/pubmed/33727866 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JEP.S265288 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|